RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NERV
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Wednesday for Minerva Neurosciences
(Updated on Mar 27, 2024)

Sell candidate since Feb 22, 2024 Loss -65.52% PDF

The Minerva Neurosciences stock price fell by -2.72% on the last day (Wednesday, 27th Mar 2024) from $2.57 to $2.50. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 7.38% from a day low at $2.44 to a day high of $2.62. The price has fallen in 7 of the last 10 days and is down by -11.35% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 thousand shares and in total, 35 thousand shares were bought and sold for approximately $86.79 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -40.76% during the next 3 months and, with a 90% probability hold a price between $0.0594 and $5.30 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NERV Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Minerva Neurosciences stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.62 and $5.00. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 06, 2024, and so far it has fallen -79.95%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Minerva Neurosciences stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.180 between high and low, or 7.38%. For the last week the stock has had daily average volatility of 6.19%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NERV) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Minerva Neurosciences to open at $2.52, and during the day (based on 14 day Average True Range), to move between $2.06 and $2.94, which gives a possible trading interval of +/-$0.443 (+/-17.71%) up or down from last closing price. If Minerva Neurosciences takes out the full calculated possible swing range there will be an estimated 35.41% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $2.63, some $0.130 (5.20%) from the current price of $2.50, our system finds the risk reward not very attractive.

Is Minerva Neurosciences stock A Buy?

Minerva Neurosciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.112 Sell Candidate Unchanged

Predicted Opening Price for Minerva Neurosciences of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$2.52 ( 0.80%) $2.50

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NERV

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.70 8.00 %
R2 2.63 5.25 %
R1 2.59 3.55 %
Current price: 2.50
Support S1 2.45 -1.95 %
S2 2.41 -3.65 %
S3 2.34 -6.40 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.83 13.20 %
R2 2.80 12.00 %
R1 2.63 5.20 %
Current price 2.50
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Minerva Neurosciences Stock and on which exchange is it traded?
The symbol for Minerva Neurosciences is NERV and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Minerva Neurosciences Stock?
Minerva Neurosciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Minerva Neurosciences Stock?
Minerva Neurosciences Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Minerva Neurosciences Stock.

What's the current price of Minerva Neurosciences Stock?
As of the end of day on the 2024-03-27, the price of an Minerva Neurosciences (NERV) share was $2.50.

What is the 52-week high and low for Minerva Neurosciences Stock?
The 52-week high for Minerva Neurosciences Stock is $13.49 and the 52-week low is $1.58.

What is the market capitalization of Minerva Neurosciences Stock?
As of the 2024-03-27, the market capitalization of Minerva Neurosciences is 17.484M.

When is the next earnings date for Minerva Neurosciences?
The upcoming earnings date for Minerva Neurosciences is May 20, 2024.
Click to get the best stock tips daily for free!

About Minerva Neurosciences

Minerva Neurosciences Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, ... NERV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT